{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:28:11Z","timestamp":1790987291546,"version":"4.1.0"},"reference-count":47,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.2217\/fmb.09.63","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T15:46:12Z","timestamp":1251819972000},"page":"807-818","source":"Crossref","is-referenced-by-count":11,"title":["Managing the microbiological safety of blood for transfusion: A us perspective"],"prefix":"10.1080","volume":"4","author":[{"given":"Roger","family":"Dodd","sequence":"first","affiliation":[{"name":"American Red Cross, Holland Laboratory, 15601 Crabbs Branch Way, Rockville, MD20855, USA.Tel.:  Fax:"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,9]]},"reference":[{"key":"e_1_3_2_3_1_1","first-page":"3","article-title":"Current estimates of transfusion safety worldwide.","volume":"120","author":"Dodd RY","year":"2005","unstructured":"Dodd RY : Current estimates of transfusion safety worldwide.Dev. Biol. (Basel)120 , 3\u201310 (2005).","journal-title":"Dev. Biol. (Basel)"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.1997.0110155"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040085"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-6892.2004.00503.x"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/tm.2001.26956"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00023.x"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00571.x"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01276.x"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00424.x"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02195.x"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6189183"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6200936"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6324345"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1001.020714"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/524889"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106283442603"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01825.x"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2005.02.004"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00337.x"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2001.19946"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00167.x"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030969"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044333"},{"key":"e_1_3_2_3_24_1","first-page":"1A","article-title":"US blood donor screening for Trypanosoma cruzi: clinical studies and early assessment of prevalence.","volume":"47","author":"Stramer SL","year":"2008","unstructured":"Stramer SL , FosterGA, HerronRMet al.: US blood donor screening for Trypanosoma cruzi: clinical studies and early assessment of prevalence.Transfusion47(Suppl. 3) , 1A (2008) (Abstract).","journal-title":"Transfusion"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01248.x"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02192.x"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41121493.x"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2006.09.016"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.55.091902.103831"},{"issue":"6","key":"e_1_3_2_3_30_1","first-page":"671","article-title":"Current risk for transfusion transmitted infections.","volume":"14","author":"Dodd RY","year":"2007","unstructured":"Dodd RY : Current risk for transfusion transmitted infections.Curr. Opin. Hematol.14(6) , 671\u2013676 (2007).","journal-title":"Curr. Opin. Hematol."},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00833.x"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69897-8"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00765.x"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2009.00916.x"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01772.x"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01771.x"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp078013"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030201"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61779-6"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00740.x"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2007.09.001"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/595010"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00957.x"},{"key":"e_1_3_2_4_2_1","unstructured":"US FDA. www.fda.gov\/cber\/products\/testkits.htm"},{"key":"e_1_3_2_4_3_1","unstructured":"US FDA. www.fda.gov\/BiologicsBloodVaccines\/NewsEvents\/WorkshopsMeetingsConferences\/ucm090641.htm"},{"key":"e_1_3_2_4_4_1","unstructured":"Health Protection Agency. Variant Creutzfeldt Jakob and plasma products. www.hpa.org.uk\/webw\/HPAweb&HPAwebStandard\/HPAweb_C\/1195733818681?p=1225960597236%94"},{"key":"e_1_3_2_4_5_1","unstructured":"US FDA. Please click here."}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb.09.63","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:38:58Z","timestamp":1719124738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb.09.63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.2217\/fmb.09.63"],"URL":"https:\/\/doi.org\/10.2217\/fmb.09.63","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}